PATENT CLAIM ANALYSIS

Application Number: 15893104
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["435", "475000"]

Abstract:
The present disclosure provides methods and kits for generating recombinant bacteriophage genomes. Specifically, the present technology provides methods of integrating a heterologous nucleic acid sequence into a bacteriophage DNA genome, and isolating recombinant bacteriophages that express the heterologous nucleic acid sequence.

Claim (Index 6):
The method of  claim 5 , wherein the heterologous nucleic acid sequence comprises a 5\u2032 flanking region that is homologous to the 3\u2032 end of the first cleaved bacteriophage genomic fragment, and a 3\u2032 flanking region that is homologous to the 5\u2032 end of the second cleaved bacteriophage genomic fragment.

Metadata:
- Claim Count in Document: 77.0
- Percentile: 88.0
- Lexical Diversity: 1.45161
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15893094', '15179912', '14293498', '15420936', '14523799']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.599868937560676
- 35 USC 102 Novelty (BERT): 0.6270157538128491
- Combined Prediction Score: 0.6025836191858934
- Mean Citation Score: 468.44034800000014
- Max Citation Score: 692.9609
- Similarity Product: 513.1963030943812

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test